Insider Transactions in Q4 2020 at Pulmonx Corp (LUNG)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 05
2020
|
Staffan Lindstrand Director |
BUY
Conversion of derivative security
|
Indirect |
1,133,728
+23.5%
|
-
|
|
Oct 05
2020
|
Dana G Mead Jr. |
BUY
Open market or private purchase
|
Direct |
26,315
+50.0%
|
$499,985
$19.0 P/Share
|
|
Oct 05
2020
|
Dana G Mead Jr. |
BUY
Conversion of derivative security
|
Indirect |
1,524,109
+21.97%
|
-
|
|
Oct 05
2020
|
Georgia Melenikiotou |
BUY
Open market or private purchase
|
Direct |
26,315
+50.0%
|
$499,985
$19.0 P/Share
|
|
Oct 05
2020
|
Richard Ferrari |
BUY
Open market or private purchase
|
Direct |
13,157
+44.84%
|
$249,983
$19.0 P/Share
|
|
Oct 05
2020
|
Richard Ferrari |
BUY
Conversion of derivative security
|
Direct |
3,030
+50.0%
|
-
|
|
Oct 05
2020
|
Richard Ferrari |
BUY
Conversion of derivative security
|
Indirect |
1,221,489
+25.79%
|
-
|
|
Oct 05
2020
|
Daniel P Florin |
BUY
Open market or private purchase
|
Indirect |
15,789
+50.0%
|
$299,991
$19.0 P/Share
|
|
Oct 05
2020
|
Boston Scientific Corp > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
5,987,965
+11.16%
|
-
|